The Stress Urinary Incontinence market report provides current treatment practices, emerging drugs, Stress Urinary Incontinence market share of the individual therapies, current and forecasted Stress Urinary Incontinence market Size from 2018 to 2030 segmented by seven major markets. The Report also covers current Stress Urinary Incontinence treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Stress Urinary Incontinence Overview
Stress Urinary incontinence, which is also known as the loss of bladder control is a common problem in which a person leaks urine by chance. Although, it may happen to anyone but older people specially women are severely affected by this problem.
Download free sample copy- https://www.delveinsight.com/sample-request/stress-urinary-incontinence-market
List of regions covered in the report
List of companies involved in the report
Stress Urinary Incontinence Market: Outlook
The Urinary Incontinence market is segmented into behavioral techniques, muscle exercises, electrical stimulation, medications, and interventional therapies, among others. However, treatment for urinary incontinence depends on the type of incontinence, its severity, and the underlying cause. The therapeutic modalities have been designed based on a better understanding of the pathogenesis of Urinary Incontinence.
Stress Urinary Incontinence Market: Treatment
For the treatment of urinary incontinence, doctors might suggest behavioral techniques, such as bladder training to delay the urination, double voiding to empty the patient’s bladder completely, scheduling of toilet trips, and fluid and diet management, among others. In muscle exercises, doctors recommend exercises of tightening (contract) of the muscles, person would use to stop urinating and hold for 5 s, and then relax for 5 s.
Stress Urinary Incontinence Market: Therapeutic Market
The current therapeutic market of Urinary Incontinence is dependent on both the marketed as well as generic products. Some of the common medications used to treat urinary incontinence include anticholinergics which include oxybutynin (Ditropan XL), tolterodine (Detrol), darifenacin (Enablex), fesoterodine (Toviaz), solifenacin (Vesicare), and trospium (Sanctura).
Additionally, Mirabegron (Myrbetriq) which is used to treat urge incontinence relaxes the bladder muscle and can increase the amount of urine individual’s bladder can hold. Also, the alpha-blocker includes tamsulosin (Flomax), alfuzosin (Uroxatral), silodosin (Rapaflo), doxazosin (Cardura) and terazosin, and topical estrogen. In some cases, interventional therapies can also be used which include bulking material injection, botulinum toxin type A (Botox), and nerve stimulators.
Stress Urinary Incontinence Market: Emerging Drugs
In the coming years, the competitive landscape for the Urinary Incontinence market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market.
Download Free Sample Copy- https://www.delveinsight.com/sample-request/stress-urinary-incontinence-market
Table of Content
Stress Urinary Incontinence Market: Report Scope
Why should you buy this report?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/